The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Dansk Innovation, startups are often financed by Novartis Venture Fund, Yamanouchi Venture Capital, Index Ventures. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Index Ventures, Aravis Ventures. In the next rounds fund is usually obtained by Novartis Venture Fund, Johnson & Johnson Development Corporation, Index Ventures.
The top activity for fund was in 2006. The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2009. Opposing the other organizations, this Dansk Innovation works on 18 percentage points less the average amount of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Evolva, 7TM Pharma. Among the most successful fund investment fields, there are Wellness, Therapeutics. The fund has no specific favorite in a number of founders of portfolio startups.
Related Funds
Fund Name | Location |
3sbio | China, Liaoning, Shenyang |
Brazos Private Equity Partners | Dallas, Texas, United States |
Capital for Enterprise | England, Sheffield, United Kingdom |
Claridge Israel | Herzliya, Israel, Tel Aviv |
JD MRO | Beijing, Beijing, China |
L & T Property Investments | Allen Park, Michigan, United States |
L Squared Capital Partners | Chicago, Illinois, United States |
North Run Capital Partners | Boston, Massachusetts, United States |
Qianfeng Capital | - |
Riverside Medical Group | - |
Selous Venture Society | Nashville, Tennessee, United States |
SFund International | China, Hong Kong, Hong Kong Island |
Structural Capital | California, Menlo Park, United States |
Swiftsure Capital | Seattle, United States, Washington |
The Orogen Group | New York, New York, United States |
The Renewable Energy Corporation | Central, Central Region, Singapore |
U.K. Steel Enterprise | England, Sheffield, United Kingdom |
Wider Wake Networks | New York, New York, United States |
Zhonglian Baiwen | Beijing, Beijing, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Evolva | $17M | 11 Dec 2009 | Aargau, Switzerland | ||
Evolva | $30M | 22 Oct 2009 | Aargau, Switzerland | ||
Evolva | $10M | 01 Dec 2006 | Aargau, Switzerland | ||
7TM Pharma | $22M | 31 Mar 2006 | Denmark, " Denmark"} | ||
Evolva | $2M | 21 Mar 2005 | Aargau, Switzerland | ||
7TM Pharma | $7M | 28 Oct 2004 | Denmark, Capital Region of Denmark, Denmark | ||
Evolva | $14M | 16 Aug 2004 | Aargau, Switzerland | ||
7TM Pharma | $15M | 27 Sep 2001 | Denmark, " Denmark"} |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Evolva | $17M | 11 Dec 2009 | Aargau, Switzerland | ||
Evolva | $30M | 22 Oct 2009 | Aargau, Switzerland | ||
Evolva | $10M | 01 Dec 2006 | Aargau, Switzerland | ||
7TM Pharma | $22M | 31 Mar 2006 | Denmark, " Denmark"} | ||
Evolva | $2M | 21 Mar 2005 | Aargau, Switzerland | ||
7TM Pharma | $7M | 28 Oct 2004 | Denmark, Capital Region of Denmark, Denmark | ||
Evolva | $14M | 16 Aug 2004 | Aargau, Switzerland | ||
7TM Pharma | $15M | 27 Sep 2001 | Denmark, " Denmark"} |